Filing Summary: Fresenius Medical Care AG & Co. KGaA
Business Context and Reporting Period
This Form 6-K, filed on November 2, 2010, reports the third-quarter financial results for the period ending September 30, 2010. The filing serves to distribute an Investor News release (Exhibit 99.1) to U.S. investors.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached Investor News release (Exhibit 99.1), which is not included in the provided text.
The Company utilizes the following non-GAAP financial measures to supplement GAAP results:
- EBITDA: Operating income excluding interest, taxes, depreciation, and amortization.
- Free Cash Flow: A measure of cash generation after capital expenditures.
Reconciliations between these non-GAAP measures and the most comparable GAAP measures are located in the attached Investor News and the Cash Flow Statement.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. Investors must refer to the attached Investor News for comparative analysis.
Guidance, Outlook, and Risks
The filing states that the non-GAAP measures are provided to enhance understanding of current performance and future prospects. However, the text does not contain specific forward-looking guidance, management commentary on risks, contingencies, or unusual items. The Company notes that non-GAAP measures should not be used as a substitute for GAAP financial measures.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor News) for specific Q3 2010 revenue, EBITDA, and net income figures.
- Verify the reconciliation of non-GAAP EBITDA and Free Cash Flow to GAAP net income in the attached exhibit.
- Check the Cash Flow Statement within the exhibit for detailed liquidity and debt servicing data.
- Confirm any year-over-year growth rates or margin changes detailed in the full press release.